Zymeworks Inc. (ZYME) Insider Trading Disclosures
Zymeworks Inc. (ZYME) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ZYME
CIK: 1937653
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerDawn Wilshaw
Audit LocationVancouver, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14A | 2026-10-16 | 2026-12-15 | PRE 14A | 0001193125-26-424099 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-09 | FORM 4 | 0002127119-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-10-09 | — | 144 Filing | 0002127119-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-23 | 8-K | 0001193125-26-399383 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-25 | 8-K | 0001937653-26-000051 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001937653-26-000047 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001937653-26-000046 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-06 | FORM 4 | 0002104446-26-000009 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-28 | 8-K | 0001193125-26-286829 | View SEC Doc Filr Page |
| 4 | 2026-05-15 | 2026-05-13 | 4 | 0001193125-26-227140 | View SEC Doc Filr Page |
| 3 | 2026-05-15 | 2026-05-13 | 3 | 0001193125-26-227111 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-062529 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-224161 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001937653-26-000034 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001937653-26-000033 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-15 | — | SCHEDULE 13G Filing | 0001193125-26-157043 | View SEC Doc Filr Page |
| 4 | 2026-04-10 | 2026-04-09 | 4 | 0001193125-26-151265 | View SEC Doc Filr Page |
| 4 | 2026-04-10 | 2026-04-09 | 4 | 0001193125-26-151264 | View SEC Doc Filr Page |
| 3 | 2026-04-10 | 2026-04-09 | 3 | 0001193125-26-151234 | View SEC Doc Filr Page |
| 3 | 2026-04-10 | 2026-04-09 | 3 | 0001193125-26-151232 | View SEC Doc Filr Page |
| 4 | 2026-04-07 | 2026-04-06 | 4 | 0001193125-26-145305 | View SEC Doc Filr Page |
| 3 | 2026-04-07 | 2026-04-01 | 3 | 0001193125-26-145300 | View SEC Doc Filr Page |
| 8-K | 2026-04-01 | 2026-03-31 | 8-K | 0001193125-26-135610 | View SEC Doc Filr Page |
| 144 | 2026-03-06 | — | 144 Filing | 0001193125-26-097240 | View SEC Doc Filr Page |
| S-8 | 2026-03-02 | — | S-8 | 0001193125-26-084183 | View SEC Doc Filr Page |